drugset / Trial / NCT06414018

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

NCT06414018

RandomizedParallel-groupTriple-blindTreatment

Summary

The equivalent dose of sufentanil and afentanil combined with laryngeal mask was used for complex bronchoscopy to observe the intraoperative effect and the influence on the recovery of patients

Timeline

Start
2024-05-20
Primary completion
2024-12-25
Completion
2024-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfentanil Other / unclassified 10 ug/kg
Subject Sufentanil Other / unclassified 0.2 ug/kg

Indications

No indication recorded.